Publications by authors named "David W Lancki"

Claim this Profile
G
Gene regulatory networks directing myeloid and lymphoid cell fates within the immune system.
Peter Laslo, Jagan M R Pongubala, David W Lancki, Harinder Singh

Semin Immunol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
Jagan M R Pongubala, Daniel L Northrup, David W Lancki, Kay L Medina, Thomas Treiber

Nat Immunol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multilineage transcriptional priming and determination of alternate hematopoietic cell fates.
Peter Laslo, Chauncey J Spooner, Aryeh Warmflash, David W Lancki, Hyun-Jun Lee

Cell· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assembling a gene regulatory network for specification of the B cell fate.
Kay L Medina, Jagan M R Pongubala, Karen L Reddy, David W Lancki, Rodney Dekoter

Dev Cell· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development.
Runqing Lu, Kay L Medina, David W Lancki, Harinder Singh

Genes Dev· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates.
Jonathan C Walsh, Rodney P DeKoter, Hyun Jun Lee, Erica D Smith, David W Lancki

Immunity· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis